Φορτώνει......
Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
BACKGROUND: Sunitinib has become mainstay first line treatment for patients with metastatic renal clear cell carcinoma (mRCC). Still, useful predictive markers of response are lacking and urgently needed for clinical decision making. METHODS: In the present study we investigated the predictive value...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | BMC Urol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5580299/ https://ncbi.nlm.nih.gov/pubmed/28859644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0267-6 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|